
Writer
Karthik Teja Macharla
PharmD
Karthik Teja Macharla, PharmD is a Pharm.D. graduate with a strong interest in clinical research, pharmacovigilance, and medical writing. In his words, he is passionate about converting complex medical information into clear, evidence-based scientific communication, committed to contributing to patient safety and advancing healthcare through accurate and impactful medical content.
73
Articles written or reviewed
About Karthik
Karthik Teja Macharla (PharmD) is a writer at Pharmacally, with 73 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Karthik Teja Macharla
Health TidingsSarepta Initiates New ENDEAVOR Cohort to Reduce ELEVIDYS Liver Toxicity Risk in Duchenne
Clinical TrialsBayer Reports Positive Phase III FIND-CKD Results for Finerenone
Drugs Safety AlertLilly Warns Compounded Tirzepatide Mixed with B12 May Pose Risks
New Drug ApprovalFDA Approves Johnson & Johnson’s TECNIS PureSee IOL for Cataract Surgery, Offering Extended Depth of Focus Vision
New Drug ApprovalEuropean Commission Approves Every-4-Week Dosing of Pegunigalsidase Alfa for Adults with Fabry Disease
New Drug ApprovalFDA Approves Wellcovorin (Leucovorin Calcium) as First Treatment for Rare FOLR1-Related Cerebral Folate Deficiency
Health TidingsGSK Licenses Linerixibat to Alfasigma in Deal Worth Up to $690 Million
Health TidingsDr. Vinay Prasad to Step Down as FDA CBER Director After Year of Regulatory Initiatives, Commissioner Makary Confirms
Clinical TrialsJOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 StudyOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala